key: cord-1006970-p80sewn1
authors: Radermacher, Peter; Calzia, Enrico; McCook, Oscar; Wachter, Ulrich; Szabo, Csaba
title: To the Editor:
date: 2020-06-23
journal: Shock
DOI: 10.1097/shk.0000000000001602
sha: 77cfdc14437f5cf4adbc75706b9992edc09119c2
doc_id: 1006970
cord_uid: p80sewn1

nan

To the Editor:

Since its recognition as the ''3rd gaseous mediator,'' the role of hydrogen sulfide (H 2 S) has been equivocally discussed in the context of acute lung injury. Depending on the experimental model, both its protective and deleterious effects were reported. However, in viral lung diseases, e.g., paramyxovirus and respiratory syncytial virus infection, both endogenous as well as exogenously delivered H 2 S were shown to be protective due to direct antiviral activity in addition to its well-established anti-inflammatory properties (1) . Therefore, we read with interest the recent report by Renieris et al. (2) on the relation between serum H 2 S concentrations and outcome in patients with SARS-Cov-2-coronavirus pneumonia. The authors reported that survivors presented with significantly higher H 2 S levels at days 1 and 7; moreover, mortality was increased when H 2 S levels decreased by more than one-third over time. Finally, a threshold value of approximately 150 mM H 2 S allowed differentiation between survivors and non-survivors. The authors concluded that serum H 2 S concentrations could be a marker of severity in patients with SARS-CoV-2-coronavirus pneumonia. Consequently, maintaining endogenous H 2 S availability and/or even exogenous H 2 S supplementation via slow releasing compounds may represent a therapeutic approach in these patients.

We are struck, however, by the high absolute values of the H 2 S concentrations reported in the study, which were measured using the monobromobimane derivatization assay followed by reverse phase high performance liquid chromatography separation (3): according to Figure 1A and B of the study, median serum H 2 S concentrations on days 1 and 7 were 188 versus 129 and 177 versus 55 mM in survivors and non-survivors, respectively, the highest individual value measured being approx. 383 mM. These H 2 S concentrations are about two orders of magnitude higher than those reported by others using this method for blood and/or tissue H 2 S quantification in mice, rats (3), swine (4-6), and humans (healthy volunteers and patients) (7, 8) . Administration of Na 2 S in rats (bolus injection of 4 mg/kg, continuous i.v. infusion of 20 mg/kg/h (3)) and swine (maximum infusion rate 2 mg/kg/h (4-6)) only increased H 2 S levels to a maximum of 2.5 to 6.5 mM. Although the reported plasma levels of H 2 S very much depend on the experimental method used, high micromolar H 2 S plasma concentrations have to be questioned based on the physico-chemical properties of H 2 S: the gas/water coefficient of distribution for H 2 S is 0.39, and at physiological pH and at 378C, 20% of the total free sulfide is present as dissolved gas (9) . Assuming that only 20% of physically dissolved H 2 S gas, i.e., 4% to 10% of the total free sulfide, disappears from a blood sample with an H 2 S concentration of the above-mentioned approx. 150 mM into the head space due to volatilization (9) , this blood sample would smell like rotten eggs, since the human nose' odor threshold is at 1 mM solutions (9) . Finally, while baseline H 2 S levels in rats measured using the same technique were 0.74 mM, H 2 S levels of 51 mM upon Na 2 S administration were lethal (10) .

Potential pitfalls of the different methods to measure H 2 S concentrations in biological samples have been highlighted previously (9) . Clearly, the monobromobimane assay per se does not solely measure free sulfide concentrations in blood serum or plasma samples due to interferences with the total sulfide pool. Moreover, the measured values largely depend on the analytical conditions, i.e., alkylation time, light exposure, tight temperature control, the actual monobromobimane concentrations used, pH, and/or the presence or absence of chelators (e.g., in the tubing used for blood sampling) (11, 12) .

These pronounced discrepancies between reported data on H 2 S concentrations have two major consequences: no direct relation between measured blood H 2 S concentrations and biologic effects of therapeutic approaches modulating the H 2 S are possible, and unless rigorously standardized procedures, which are based on consensus statements (e.g., as for the use of the single-cell gel electrophoresis (''comet assay''), are used even for the same analytical method, the absolute values of the data reported from different studies cannot be compared. Nevertheless, the trends and directions observed within the same study, when all the samples were analyzed by the same method, can, remain valid. Thus, the above methodological concerns (i.e., the uncertain chemical nature of the species measured by the method used here) do not necessarily question the primary conclusions of the study discussed above (2), i.e., that low H 2 S concentrations-or probably more broadly, low 'reactive sulfur species concentrations correlate with worse outcomes in SARS-CoV-2-coronavirus pneumonia patients. Nevertheless, follow-up studies to confirm these findings (preferably, using independent, different methods of H 2 S or reactive species analysis) are recommended. Moreover-if the inverse correlation between H 2 S levels and SARS-CoV-2 outcomes is, indeed confirmed-the potential therapeutic effect of H 2 S donation on the outcome of SARS-CoV-2 could also be tested, first in preclinical models, and if positive, potentially in subsequent translational studies as well.

Hydrogen sulfide: a novel player in airway development, pathophysiology of respiratory diseases, and antiviral defenses

Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 Coronavirus

A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood

Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury

Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass

Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection

Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease

Metabolism of sulfur compounds in homocystinurias

A practical look at the chemistry and biology of hydrogen sulfide

H2S concentrations in the arterial blood during H2S administration in relation to its toxicity and effects on breathing

Chemical aspects of hydrogen sulfide measurements in physiological samples

Comprehensive analysis of how experimental parameters affect H2S measurements by the monobromobimane method

Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus

This work is supported by the DFG (CRC 1149; GRK 2203).

To the Editor: We read with great interest the comments addressed by Radermacher et al. (1) on our publication regarding the importance of hydrogen sulfide (H 2 S) for the prognosis and outcome of severe infection caused by the novel SARS-CoV-2 (also known as Covid-19) (2) . Although serum H 2 S levels as high as 249 mM and 580 mM have been demonstrated in patients with septic shock (3) and severe asthma (4), we agree that the elevated serum H 2 S is an intriguing finding. We tried to deliver some answers that are based on: the performance of the used assay in healthy volunteers and in patients with other types of severe lung infection; and the reproducibility of the data by using another assay.We measured levels of H 2 S in 17 healthy volunteers and in 60 patients with ventilator-associated pneumonia (VAP). VAP was diagnosed according to standard definitions (5) and all patients had microbiological confirmation with one Gram-negative pathogen isolated in counts greater than 10 5 colony-forming units/mL from the bronchoalveolar lavage by the culture technique already described (6) . Isolated pathogens were Acinetobacter baumannii (n ¼ 23), Pseudomonas aeruginosa (n ¼ 19), and Klebsiella pneumoniae (n ¼ 18). Blood samples were collected within the first 24 h from diagnosis of VAP and H 2 S was measured by the monobromobimane derivatization assay followed by reverse phase HPLC separation (2) . Results clearly showed that survivors from Covid-19 had H 2 S levels significantly greater than healthy population and patients with VAP (Fig. 1) . This elaborates the hypothesis that it is not the assay that leads to false-positive increased H 2 S levels, but that H 2 S increase may well be an intrinsic characteristic of Covid-19 described for the first time herein. H 2 S of healthy was also within reported ranges (7) .To strengthen the finding of increased H 2 S in Covid-19 survivors, H 2 S was measured in the same samples by a photometric methylene blue assay (8) . Despite the lack of specificity of this assay leading to higher measurable levels, the interpretation of the findings was the same (Fig. 2) .We feel that Covid-19 is a new territory of research where modulation of H 2 S plays a major role and we wish to thank Rademacher et al. (1) for paving us the way to strengthen our data.